Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
Poseida Therapeutics, Inc. (PSTX)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
06/15/2023Collins CynthiaDirectorGrantCommon Stock19.6k$0.00$0 06/15/2023
06/15/2023Collins CynthiaDirectorGrantStock Option (Right to buy)27.4k$2.47$67.6k 06/15/2023
06/15/2023Lloyd Marcea BlandDirectorGrantCommon Stock19.6k$0.00$0 06/15/2023
06/15/2023Lloyd Marcea BlandDirectorGrantStock Option (Right to buy)27.4k$2.47$67.6k 06/15/2023
06/15/2023Schmid John P.DirectorGrantCommon Stock19.6k$0.00$0 06/15/2023
06/15/2023Schmid John P.DirectorGrantStock Option (Right to buy)27.4k$2.47$67.6k 06/15/2023
06/15/2023BAUM CHARLES MDirectorGrantCommon Stock19.6k$0.00$0 06/15/2023
06/15/2023BAUM CHARLES MDirectorGrantStock Option (Right to buy)27.4k$2.47$67.6k 06/15/2023
06/15/2023Corning LukeDirectorGrantCommon Stock19.6k$0.00$0 06/15/2023
06/15/2023Corning LukeDirectorGrantStock Option (Right to buy)27.4k$2.47$67.6k 06/15/2023
05/01/2023Amado RafaelDirectorGrantCommon Stock39.3k$0.00$0 05/01/2023
05/01/2023Amado RafaelDirectorGrantStock Option (Right to Buy)55.2k$2.76$152.4k 05/01/2023
03/01/2023LEONHARDT HARRY JGC & Chief Compliance OfficerGrantCommon Stock92.8k$0.00$0 03/01/2023
03/01/2023LEONHARDT HARRY JGC & Chief Compliance OfficerPayment of ExerciseCommon Stock4.3k$5.35$23.1k 03/01/2023
03/01/2023LEONHARDT HARRY JGC & Chief Compliance OfficerGrantEmployee Stock Option (Right to Buy)125.3k$5.35$670.3k 03/01/2023
03/01/2023Gergen Mark JPresident and CEOGrantCommon Stock269.6k$0.00$0 03/01/2023
03/01/2023Gergen Mark JPresident and CEOGrantEmployee Stock Option (Right to Buy)364.1k$5.35$1.9M 03/01/2023
03/01/2023Mylet JohannaCFOGrantCommon Stock92.8k$0.00$0 03/01/2023
03/01/2023Mylet JohannaCFOPayment of ExerciseCommon Stock4.3k$5.35$23.1k 03/01/2023
03/01/2023Mylet JohannaCFOGrantEmployee Stock Option (Right to Buy)125.3k$5.35$670.3k 03/01/2023
03/01/2023Warner BrentPresident, Gene TherapyGrantCommon Stock92.8k$0.00$0 03/01/2023
03/01/2023Warner BrentPresident, Gene TherapyPayment of ExerciseCommon Stock26.6k$5.35$142.4k 03/01/2023
03/01/2023Warner BrentPresident, Gene TherapyGrantStock Option (Right to Buy)125.3k$5.35$670.3k 03/01/2023
08/08/2022Ostertag EricExecutive ChairmanPurchaseCommon Stock142.9k$3.50$500k 08/08/2022
08/08/2022Malin Life Sciences Holdings Ltd10% OwnerPurchaseCOMMON STOCK2.2M$3.50$7.5M 08/08/2022
08/03/2022Ostertag EricExecutive ChairmanSaleCommon Stock160.7k$3.69$592.8kSee footnote08/03/2022
06/16/2022Lloyd Marcea BlandDirectorGrantCommon Stock19.6k$0.00$0 06/16/2022
06/16/2022Lloyd Marcea BlandDirectorGrantStock Option (Right to Buy)28.5k$2.01$57.3k 06/16/2022
06/16/2022Collins CynthiaDirectorGrantCommon Stock19.6k$0.00$0 06/16/2022
06/16/2022Collins CynthiaDirectorGrantStock Option (Right to Buy)28.5k$2.01$57.3k 06/16/2022
06/16/2022BAUM CHARLES MDirectorGrantCommon Stock39.3k$0.00$0 06/16/2022
06/16/2022BAUM CHARLES MDirectorGrantStock Option (Right to Buy)57k$2.01$114.6k 06/16/2022
06/16/2022Schmid John P.DirectorGrantCommon Stock19.6k$0.00$0 06/16/2022
06/16/2022Schmid John P.DirectorGrantStock Option (Right to Buy)28.5k$2.01$57.3k 06/16/2022
06/16/2022Corning LukeDirectorGrantCommon Stock19.6k$0.00$0 06/16/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy